Navigation Links
InterMune Reports Results from Triple Combination Study of ITMN-191
Date:1/12/2009

investor relations page of InterMune's corporate website at www.intermune.com.

Dr. Stefan Zeuzem, Professor of Medicine, Chief of the Department of Medicine at the J.W. Goethe University Hospital in Frankfurt, Germany and protocol chair of this study said, "Based on the totality of the viral kinetic data, in particular BLQ, a robust predictor of virologic outcome, the q12h and q8h regimens delivered very convincing viral kinetic results and appeared to perform very comparably in this 14-day study. The safety and tolerability profile of ITMN-191 in both the earlier monotherapy study and in the present triple combination study was also encouraging, as no issues of concern were observed. We look forward to the completion of the planned Phase 2b study to determine if the very promising profile of ITMN-191 observed will be confirmed."

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "We are very pleased to report that in this 14-day study, both the q12h and q8h regimens of ITMN-191 delivered viral kinetic performance that we believe is very competitive with that reported to date for other protease inhibitors in similar experiments. In addition, the strong safety and tolerability profile of ITMN-191 observed in prior Phase 1 experiments was reinforced in this study, even in the presence of standard-of-care therapy and at doses significantly higher than those used in monotherapy." Mr. Welch continued, "We believe that the viral kinetic and safety results reported today provide evidence that ITMN-191 has the potential to deliver superior sustained virologic response (SVR) rates on an intent-to-treat basis. In pursuit of this goal, our Phase 2b study, anticipated to begin in the second quarter of 2009, will study both q12h and q8h regimens and both 12 and 24-week treatment durations."

Phase 1b Triple Combination Trial Design
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. InterMune to Present at Thomas Weisel Partners Healthcare Conference
2. Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
3. InterMune to Present at the 2008 Wachovia Healthcare Conference
4. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
5. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
6. Allscripts Reports Fiscal 2009 Second Quarter Results
7. MDS Reports Final Fourth-Quarter 2008 Results
8. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
9. Cardium Reports on Exchange Listing With NYSE Alternext US
10. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
11. Joint Commission Reports Positive Survey Results for CHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 A group of ... for Longevity, today, in reaction to a recent statement by ... of brain training and derogated the efficacy of all brain ... agreed with the parts of the center’s statement critical of ... the center had also overstated its case, in a document ...
(Date:12/17/2014)... FL (PRWEB) December 17, 2014 No ... not been able to eradicate the head louse parasite—a ... hassle for parents. Each year between six and twelve ... Troopers, the Miami-based lice removal treatment company comes to ... non-toxic and environmentally friendly. With its track record of ...
(Date:12/17/2014)... Project Veritas is releasing a video interview of ... and Obamacare architect Jonathan Gruber to public attention. Award-winning ... which is being distributed on YouTube. , During the ... the Affordable Care Act in order to hide a ... per year tax grab. , “President Obama promised us ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... diseases, one worrisome phenomenon is when an illness that originated ... known as zoonosis -- is not uncommon and keeps researchers ... animal-borne disease might make inroads into the human population. ... and the culprits in this case were guinea pigs. More ...
(Date:12/17/2014)... -- Poor students get more fruits and vegetables at school ... But, the opposite is true for students from wealthier families. ... school may give a healthy boost to poor students, diets, ... family income level, students all ate a similar amount of ... study was published recently in the journal Preventive Medicine ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Poor Students Eat Healthier Foods at School, Study Finds 2
... in broccoli and cabbage works by lowering the activity ... according to a University of California, Berkeley, study appearing ... journal Proceedings of the National Academy of Sciences ... trials in humans because it was found to stop ...
... its continued commitment to,transparency, Cleveland Clinic is implementing ... timely information about their doctors,professional background, as well ... Recently, Cleveland Clinic ... current directory of all its physicians, listing,their educational ...
... 3 Their goal is ambitious. They want to reach out ... doctors advise it and still, behavior is not changing fast enough. , ... go to: http://www.prnewswire.com/mnr/beyondboobs/36272/ , , ... Bowditch, co-founder of Beyond Boobs. And what message is she referring to? ...
... Ninety Four Percent Link IT Hurdles to Missed or Delayed Diagnosis;,Almost ... ... Chicago (PRWEB) December 3, 2008 -- A national survey released today ... challenges that are hindering radiologists, ability to control skyrocketing demand and ...
... research center focused,on improving the quality of life of ... Chattanooga, led by a world-renowned researcher whose,concepts and tools ... The Siskin Center for Child and Family Research ... nonprofit organization focused,on education, outreach and support for children ...
... ("Bally"),today announced that it has filed for voluntary chapter ... today in the U.S. Bankruptcy,Court for the Southern District ... chapter,11 process to significantly reduce debt from its balance ... expects to accomplish,these goals through either a sale of ...
Cached Medicine News:Health News:Broccoli compound targets key enzyme in late-stage cancer 2Health News:Broccoli compound targets key enzyme in late-stage cancer 3Health News:Cleveland Clinic Boosts Transparency, Makes Physician Disclosures Available Online 2Health News:Cleveland Clinic Boosts Transparency, Makes Physician Disclosures Available Online 3Health News:Photos: 'Changing Behavior, One Woman at a Time' 2Health News:Photos: 'Changing Behavior, One Woman at a Time' 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 2Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 3Health News:National Survey of Radiologists Reveals Systemic Problems Hurting Industry and Patient Care 4Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 2Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 3Health News:Siskin Center for Child and Family Research to Focus on Early Childhood Development and Special Education 4Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 2Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 3
(Date:12/15/2014)... , Dec. 15, 2014 As medical device ... Product Labeling) markup language standard, content teams have a ... skills to work with the standard. Starting January 2015, ... three webinars on the benefits and the critical aspects ... will be facilitated by Howard Shatz , DCL,s ...
(Date:12/15/2014)... , Dec. 15, 2014  The Government of Ghana ... AABB, Global Blood Fund (GBF) and Terumo BCT to respond to ... as well as provide long-term health system capacity to the citizens ... , The Ghanaian Ebola Readiness and Resilience Initiative (GERRI) is ... preparations for the possible arrival of the Ebola epidemic ...
(Date:12/13/2014)... Research and Markets ( http://www.researchandmarkets.com/research/2r6bmg/drug_injection ... "Drug Injection Devices to 2020" report to ... As new drugs become available ... health conditions, drug developers have increasingly pursued packaging ... and increase the efficiency and reliability with which ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... (NYSE: GSK ) announced today that the U.S. Food ... patients with advanced renal cell carcinoma (RCC), a form of ... diagnosed with kidney cancer this year, and 13,000 people will ... malignancy of the kidney and is highly resistant to chemotherapy," ...
... Scientific Corporation (NYSE: BSX ) today announced financial results ... as guidance for net sales and earnings per share (EPS) ... Third quarter highlights (Sales growth rates are constant currency): ... achieved adjusted EPS of $0.19, both within the Company,s guidance ...
Cached Medicine Technology:FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer 2FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer 3FDA approves GlaxoSmithKline's VOTRIENT(TM) for advanced renal cell cancer 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 25Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 26Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 27Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 28Boston Scientific Announces Results for Third Quarter Ended September 30, 2009 29
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: